| Incidence studies |
Follow-up length |
Country |
Clinical endpoint |
| Marniemi et al. [21] |
10 years |
Finland |
Fatal/non-fatal coronary events |
| Giovannucci et al. [8] |
10 years |
USA |
Fatal coronary heart disease events and non-fatal MI |
| Wang et al. [6] |
7.6 years |
USA |
First fatal/non-fatal cardiovascular events |
| Bolland et al. [22] |
5 years |
New Zealand |
MI |
| Mortality studies |
|
|
| Dobnig et al. [23] |
7.7 years |
Germany |
Cardiovascular death |
| Melamed et al. [2] |
8.7 years |
USA |
Cardiovascular death |
| Pilz et al. [24] |
6.2 years |
Netherlands |
Cardiovascular death |
| Kilkkinen et al. [25] |
27.1 years |
Finland |
Cardiovascular death |
| Semba et al. [26] |
6.5 years |
Italy |
Cardiovascular death |
|
